Molecular Diagnostic For Infectious Diseases Market Scope And Analysis

Report Code : TIPRE00030044
Category : Medical Device

Status : Published
No. of Pages : 331

Buy Now

Molecular Diagnostic for Infectious Diseases Market Scope and Analysis by 2030

Buy Now

Molecular Diagnostic for Infectious Diseases Market Report Scope

Report Attribute	Details
Market size in 2022	US$ 6.88 Billion
Market Size by 2030	US$ 17.61 Billion
Global CAGR (2022 - 2030)	12.5%
Historical Data	2020-2021
Forecast period	2023-2030
Segments Covered	By Type Point-of-Care Testing Laboratory Testing By End User Point-of-Care Testing Laboratory Testing By Application Point-of-Care Testing Laboratory Testing By Disease Type Point-of-Care Testing Laboratory Testing
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	F Hoffmann La Roche Ltd Abbott Laboratories Thermo Fisher Scientific Inc bioMerieux SA Danaher Corp Hologic Inc Siemens Healthineers AG Bruker Corp Molzym GmbH Co KG DiaSorin SpA

Molecular Diagnostic for Infectious Diseases Market News and Recent Developments

The Molecular Diagnostic for Infectious Diseases Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the molecular diagnostic for infectious diseases market are listed below:

Thermo Fisher Scientific launched PCR kits for infectious disease detection in India. Thermo Fisher Scientific announced that its Applied Biosystems TaqPath PCR kits for infectious diseases such as multi-drug-resistant tuberculosis (MTB MDR), M. tuberculosis complex (MTB), hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and for genetic analysis (HLA B27) have received licensing rights by the Central Drugs Standard Control Organisation (CDSCO) and will be manufactured in India in association with Mylab Discovery Solutions. (Source: Thermo Fisher Scientific Inc, Company Website, February 2023)
Bruker Introduced New Mycobacteria and Fungi IVD Solutions for MALDI Biotyper, and a Novel LiquidArray Gastrointestinal Syndromic Panel. With the introduction of new IVD workflows, kits, software and reference libraries for mycobacteria and fungi, the company further expand the applications of established MALDI Biotyper platform. This creates additional value for all current and future customers. The new LiquidArray Gastrointestinal is a next-generation syndromic panel with amazing pathogen coverage. It is ideal for laboratories which are interested in a broad screening approach to detect most pathogens in one run. (Source: Bruker Corp, Company Website, April 2023)

Molecular Diagnostic for Infectious Diseases Market Report Coverage and Deliverables

The “Molecular Diagnostic for Infectious Diseases Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering below areas:

Molecular diagnostic for infectious diseases market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Molecular diagnostic for infectious diseases market trends as well as market dynamics such as drivers, restraints, and key opportunities
Detailed PEST/Porter’s Five Forces and SWOT analysis
Molecular diagnostic for infectious diseases market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the molecular diagnostic for infectious diseases market
Detailed company profiles